Cargando…
Rethinking immune checkpoint blockade: ‘Beyond the T cell’
The clinical success of immune checkpoint inhibitors has highlighted the central role of the immune system in cancer control. Immune checkpoint inhibitors can reinvigorate anti-cancer immunity and are now the standard of care in a number of malignancies. However, research on immune checkpoint blocka...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817791/ https://www.ncbi.nlm.nih.gov/pubmed/33468555 http://dx.doi.org/10.1136/jitc-2020-001460 |